"Today, the U.S. Food and Drug Administration issued a proposal designed to assist companies developing new treatments for patients in the early stages of Alzheimer's disease, before the onset of noticeable (overt) dementia.
Exelon Patch Patient Information including If I Miss a Dose
In this Article
- What is rivastigmine transdermal (Exelon Patch)?
- What are the possible side effects of rivastigmine transdermal (Exelon Patch)?
- What is the most important information I should know about rivastigmine transdermal (Exelon Patch)?
- What should I discuss with my healthcare provider before using rivastigmine transdermal (Exelon Patch)?
- How should I use rivastigmine transdermal (Exelon Patch)?
- What happens if I miss a dose (Exelon Patch)?
- What happens if I overdose (Exelon Patch)?
- What should I avoid while using rivastigmine transdermal (Exelon Patch)?
- What other drugs will affect rivastigmine transdermal (Exelon Patch)?
- Where can I get more information?
What happens if I miss a dose (Exelon Patch)?
If you forget to change the skin patch, remove it and apply a new one as soon as you remember. Do not wear extra patches to make up a missed dose.
Call your doctor for instructions if you miss more than 3 doses of rivastigmine.
What happens if I overdose (Exelon Patch)?
Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.
Overdose symptoms may include severe forms of some of the side effects listed in this medication guide.
What should I avoid while using rivastigmine transdermal (Exelon Patch)?
This medication may impair your thinking or reactions. Be careful if you drive or do anything that requires you to be alert.
Do not use any cream, lotion, ointment, oil, or powder on the skin where you plan to apply a skin patch. The patch may not stick well to the skin.
Avoid applying heat to the skin where the patch is worn, because it may increase the amount of medicine your body absorbs. Heat sources include hot tubs, heating pads, heat lamps, saunas, heated water beds, and direct sunlight.
Avoid touching your eyes after handling a skin patch.
What other drugs will affect rivastigmine transdermal (Exelon Patch)?
Do not take rivastigmine capsules or oral liquid at the same time you are wearing the skin patch.
Tell your doctor about all other medicines you use, especially:
- atropine (Atreza, Sal-Tropine), belladonna (Donnatal, and others), benztropine (Cogentin), dimenhydrinate (Dramamine), methscopolamine (Pamine), or scopolamine (Transderm Scop);
- bladder or urinary medicines such as darifenacin (Enablex), flavoxate (Urispas), oxybutynin (Ditropan, Oxytrol), tolterodine (Detrol), or solifenacin (Vesicare);
- bronchodilators such as ipratropium (Atrovent) or tiotropium (Spiriva);
- cold or allergy medicine that contains an antihistamine;
- irritable bowel medicines such as dicyclomine (Bentyl), hyoscyamine (Anaspaz, Cystospaz, HyoMax, Levsin, and others), or propantheline (Pro Banthine);
- ulcer medications such as clidinium (Quarzan), glycopyrrolate (Robinul) or mepenzolate (Cantil);
- aspirin or other NSAIDs (non-steroidal anti-inflammatory drugs) such as ibuprofen (Advil, Motrin), naproxen (Aleve, Naprosyn, Naprelan, Treximet), celecoxib (Celebrex), diclofenac (Arthrotec, Cambia, Cataflam, Voltaren, Flector Patch, Pennsaid, Solareze), indomethacin (Indocin), meloxicam (Mobic), and others; or
- medicines used to treat Parkinson's Disease such as levodopa (Dopar, Larodopa, Sinemet, Atamet, others), bromocriptine (Parlodel, others), pergolide (Permax), pramipexole (Mirapex), or ropinirole (Requip).
This list is not complete and other drugs may interact with rivastigmine transdermal. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.
Where can I get more information?
Your pharmacist can provide more information about rivastigmine transdermal.
Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.
Every effort has been made to ensure that the information provided by Cerner Multum, Inc. ('Multum') is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 1996-2013 Cerner Multum, Inc. Version: 3.01. Revision date: 10/16/2012.
Your use of the content provided in this service indicates that you have read,understood and agree to the End-User License Agreement,which can be accessed by clicking on this link.
Additional Exelon Patch Information
Exelon Patch - User Reviews
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get breaking medical news.